Jones Lang LaSalle Americas, Inc (“JLL”), has been retained on an exclusive basis to arrange the sale of 9001 Torresdale Ave (the “Property” or the “Offering”). The Property is a state-of-the-art, newly renovated, production ready cGMP lab building located in Philadelphia, PA.
The 63,000 square foot lab facility was constructed in 1945 and completely renovated in 2023. Over $3 million was invested into the building in the last 12 months to create a state-of-the-art lab testing facility for the previous user providing an incoming investor or user the opportunity to acquire a move-in ready lab building. The Property boasts 17'-20' clear heights as well as 6 loading doors, 3 brand new production suites, 26,000 square feet of warehouse space, and 12,600 square feet of R&D, H.P., qualitative analysis lab space providing impressive functionality. Additionally, the Property offers a high-class amenity package including a brand-new fitness center, café and conference facilities.
Located in Greater Philadelphia, the metropolitan area continues to see significant growth in the life sciences sector as $1.7 billion in venture capital funding flowed into local firms in 2022. Steady regional fundraising fundamentals have resulted in the second busiest funding year on record for the regional life sciences ecosystem and placed Greater Philadelphia in 5th place among the top life sciences clusters behind large markets such as Boston and San Diego.
9001 Torresdale is strategically positioned within minutes of on-ramps to Interstate 95 providing direct access Center City Philadelphia and the Philadelphia International Airport. The accessibility is a necessity for lab users currently in the market seeking space.
- Significant cGMP & Lab Capital Investment
- Production-Ready Lab Facility
- Highly Amenitized & Maintained Building
- Excellent Lab Configuration for a Potential Lab User
- Strategically Located in Philadelphia’s Growing Life Sciences & Pharmaceutical Hub
- Exceptional Connectivity & Access to Skilled Labor Pool